REPL - Replimune Group, Inc.
NEXT EARNINGS:
May 28, 2026
EPS Est: $-0.75
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.75
DETAILS
HIGH:
$18.00
LOW:
$11.00
MEDIAN:
$13.00
CONSENSUS:
$13.75
UPSIDE:
64.47%
Market Cap:
690.31M
Volume:
856,903
Avg Volume:
1,452,201
52 Week Range:
2.68-14.43
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.75
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
479
IPO Date:
2018-07-20
EPS (TTM):
-3.07
P/E Ratio:
-3.18
Revenue (TTM):
N/A
Total Assets:
551.33M
Total Debt:
76.17M
Cash & Equiv:
111.12M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-53.1%
Debt/Equity:
0.18
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-03 | $-0.77 | $-0.85 | +9.4% | — | $428571 | — |
| 2025-11-06 | $-0.90 | $-0.87 | -3.4% | — | $714286 | — |
| 2025-08-07 | $-0.95 | $-0.83 | -14.5% | — | $500000 | — |
| 2025-05-22 | $-0.82 | $-0.75 | -9.3% | $1.5M | — | — |
| 2025-02-12 | $-0.79 | $-0.70 | -12.9% | — | — | — |
| 2024-11-12 | $-0.68 | $-0.75 | +9.3% | — | — | — |
| 2024-08-08 | $-0.78 | $-0.88 | +11.4% | — | — | — |
| 2024-05-16 | $-0.82 | $-0.86 | +4.7% | $4.0M | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (247.30M) | (215.79M) | (174.28M) | (118.04M) | (80.87M) | (52.62M) | (30.83M) | (19.70M) | (7.70M) |
| EPS | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 | -1.54 | -1.33 | -0.64 | -0.36 |
| Total Assets | 551.33M | 487.72M | 646.59M | 461.19M | 543.10M | 234.10M | 154.33M | 65.15M | 22.82M |
| Total Debt | 76.17M | 75.87M | 60.76M | 32.84M | 33.28M | 41.79M | 6.56M | 0 | 0 |
| Cash & Equivalents | 111.12M | 74.46M | 146.59M | 105.95M | 182.52M | 59.50M | 25.70M | 17.58M | 20.59M |
| Operating Cash Flow | (192.25M) | (185.47M) | (128.05M) | (82.18M) | (61.39M) | (60.55M) | (25.38M) | (16.01M) | (7.08M) |
| Free Cash Flow | (198.94M) | (191.13M) | (130.32M) | (84.52M) | (63.78M) | (67.09M) | (27.98M) | (16.15M) | (7.32M) |
| FCF per Share | -2.47 | -2.87 | -2.24 | -1.62 | -1.38 | -1.96 | -1.21 | -0.52 | -0.34 |
| Book Value | 415.84M | 374.51M | 555.29M | 411.23M | 498.73M | 183.72M | 137.86M | (28.07M) | (11.52M) |
| Cash & ST Investments | 483.80M | 420.67M | 583.39M | 395.65M | 476.30M | 168.56M | 134.81M | 61.55M | 20.59M |
| ROC Equity | -0.59 | -0.58 | -0.31 | -0.29 | -0.16 | -0.29 | -0.22 | N/A | N/A |